(Reuters) - Glaxo said it is was on track to launch the product in the
rest of Europe during the second half of 2007. Industry
analuysts view it as a future blockbuster, although it will take
several years of additional clinical trials to reach its full
potential.
Read more at Reuters.com Government Filings News
rest of Europe during the second half of 2007. Industry
analuysts view it as a future blockbuster, although it will take
several years of additional clinical trials to reach its full
potential.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment